SCHOTT Pharma & Co and Single Use Support are joining forces to extensively test SCHOTT Pharma’s innovative solutions for the safe and efficient handling of small volumes of pharmaceuticals at ultra-low temperatures. Specialising in the growing sector of Advanced Therapy Medicinal Products (ATMPs), the cooperation focuses its efforts on drug delivery solutions and freezing applications for cell and gene therapies.

With substance handling temperatures as low as -196°C (-320°F), the aim of the collaboration is to create reliable solutions to ensure highest product quality. By joining forces and offering their combined knowledge and respective backgrounds to pharmaceutical and biotechnology companies around the globe, their customers will benefit from outcomes that focus on improved product integrity and more reliable cold chain processes, enabling them to improve patient health.

Alexandre Monzo Fuentes, Head of Sales EU at Single Use Support, is pleased about the cooperation: “With our many years of experience in the production of controlled freezing solutions, we look forward to sharing synergies with SCHOTT Pharma in developing new solutions that address the specific needs of advanced therapies.”